Genetic polymorphisms associated with coronary stenosis, methods of detection and uses thereof
View Patent ↗The present invention is based on the discovery of genetic polymorphisms that are associated with coronary stenosis. In particular, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by such nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and proteins, and methods of using the nucleic acid and proteins as well as methods of using reagents for their detection.
1. A method for identifying a human who has an altered risk for developing coronary stenosis, comprising detecting a single nuclcotide polymorphism (SNP) at position 101 of SEQ ID NO: 7605 in a nucleic acid sample from said human, wherein the presence of T at position 101 of SEQ ID NO: 7605 For one allele indicates said human is at an increased risk of developing coronary stenosis, and the presence of C at position 101 of SEQ ID NO: 7605 for both alleles indicates said human is at a decreased risk of developing coronary stenosis.
2. The method of claim 1 in which detection is carried out by a process selected from the group consisting of: allele-specific probe hybridization, allele-specific primer extension, allele-specific amplification, sequencing, 5′ nuclease digestion, molecular beacon assay, oligonucleotide ligation assay, size analysis, and single-stranded conformation polymorphism.
3. The method of claim 1 wherein said human has a history of smoking.
4. The method of claim 1 wherein said human has T at position 101 of SEQ ID NO: 7605 for both alleles thereby indicating said human is at an increased risk of developing coronary stenosis.
5. The method of claim 1 wherein said human has T at position 101 of SEQ ID NO: 7605 for one allele thereby indicating said human is at an increased risk of developing coronary stenosis.
6. The method of claim 1 wherein said human has C at position 101 of SEQ ID NO: 7605 for both alleles thereby indicating said human is at a decreased risk of developing coronary stenosis.
7. The method of claim 1 , wherein the detection is carried out by using a set of detection reagents comprising the oligonucleotide sequences of SEQ ID NO: 26185, SEQ ID NO: 26186, and SEQ ID NO: 26187.